News Quantified

TSHA – taysha gene therapies, inc. (US:NASDAQ)

Taysha Gene Therapies (TSHA) was upgraded by Truist Financial Corporation to "strong-buy".

How FDA Breakthrough Status For TSHA-102 At Taysha Gene Therapies (TSHA) Has Changed Its Investment Story [Yahoo! Finance]

Taysha Gene Therapies (TSHA) was upgraded by Wall Street Zen from "se

Taysha Gene Therapies (TSHA) had its price target raised by Needham & Company LLC from $10.00 to $12.00. They now have a "buy" rating on the stock.

Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}